Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

Source:http://linkedlifedata.com/resource/pubmed/id/19016581

Download in:

View as

General Info

PMID
19016581